These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31455587)

  • 1. Timeliness of rotavirus vaccination at sentinel sites in four early-adopter African countries.
    Pindyck T; Tate JE; Bonkoungou IJO; Armah G; Mujuru HA; Rugambwa C; Mwenda JM; Parashar U
    Vaccine; 2019 Sep; 37(40):6002-6007. PubMed ID: 31455587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.
    Tate JE; Ngabo F; Donnen P; Gatera M; Uwimana J; Rugambwa C; Mwenda JM; Parashar UD
    Clin Infect Dis; 2016 May; 62 Suppl 2():S208-12. PubMed ID: 27059358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
    Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
    Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana.
    Armah G; Pringle K; Enweronu-Laryea CC; Ansong D; Mwenda JM; Diamenu SK; Narh C; Lartey B; Binka F; Grytdal S; Patel M; Parashar U; Lopman B
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S200-7. PubMed ID: 27059357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.
    Bonkoungou IJO; Aliabadi N; Leshem E; Kam M; Nezien D; Drabo MK; Nikiema M; Ouedraogo B; Medah I; Konaté S; Ouédraogo-Traoré R; Sangaré L; Kam L; Yé D; Ouattara M; Biey JN; Mwenda JM; Tate JE; Parashar UD
    Vaccine; 2018 Nov; 36(47):7170-7178. PubMed ID: 29290478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catching-up with pentavalent vaccine: Exploring reasons behind lower rotavirus vaccine coverage in El Salvador.
    Suarez-Castaneda E; Burnett E; Elas M; Baltrons R; Pezzoli L; Flannery B; Kleinbaum D; de Oliveira LH; Danovaro-Holliday MC
    Vaccine; 2015 Nov; 33(48):6865-70. PubMed ID: 26263200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa.
    Weldegebriel G; Mwenda JM; Chakauya J; Daniel F; Masresha B; Parashar UD; Tate JE
    Vaccine; 2018 Nov; 36(47):7124-7130. PubMed ID: 29102168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study.
    Fathima P; Gidding HF; Snelling TL; McIntyre PB; Blyth CC; Sheridan S; Liu B; de Klerk N; Moore HC
    Vaccine; 2019 Sep; 37(39):5835-5843. PubMed ID: 31443995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
    Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis.
    Ngabo F; Tate JE; Gatera M; Rugambwa C; Donnen P; Lepage P; Mwenda JM; Binagwaho A; Parashar UD
    Lancet Glob Health; 2016 Feb; 4(2):e129-36. PubMed ID: 26823214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.
    Tsolenyanu E; Djadou KE; Fiawoo M; Akolly DAE; Mwenda JM; Leshem E; Tate JE; Aliabadi N; Koudema W; Guedenon KM; Godonou M; Dagnra A; Gbadoe AD; Boko A; Landoh D; Atakouma Y; Parashar UD
    Vaccine; 2018 Nov; 36(47):7185-7191. PubMed ID: 29397224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaching every child with rotavirus vaccine: Report from the 10th African rotavirus symposium held in Bamako, Mali.
    Sow SO; Steele AD; Mwenda JM; Armah GE; Neuzil KM
    Vaccine; 2017 Oct; 35(42):5511-5518. PubMed ID: 28893479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.
    Valencia-Mendoza A; Bertozzi SM; Gutierrez JP; Itzler R
    BMC Infect Dis; 2008 Jul; 8():103. PubMed ID: 18664280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.
    Muhsen K; Anis E; Rubinstein U; Kassem E; Goren S; Shulman LM; Ephros M; Cohen D
    Clin Microbiol Infect; 2018 Jan; 24(1):53-59. PubMed ID: 28442435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global impact of rotavirus vaccines.
    Tate JE; Patel MM; Steele AD; Gentsch JR; Payne DC; Cortese MM; Nakagomi O; Cunliffe NA; Jiang B; Neuzil KM; de Oliveira LH; Glass RI; Parashar UD
    Expert Rev Vaccines; 2010 Apr; 9(4):395-407. PubMed ID: 20370550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
    Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
    Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of Rotavirus Surveillance and Vaccine Introduction - World Health Organization African Region, 2007-2016.
    Mwenda JM; Burke RM; Shaba K; Mihigo R; Tevi-Benissan MC; Mumba M; Biey JN; Cheikh D; Poy MSc A; Zawaira FR; Aliabadi N; Tate JE; Hyde T; Cohen AL; Parashar UD
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1192-1196. PubMed ID: 29095805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
    Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
    Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): impact on the timeliness of uptake of the primary course of DTPa vaccine.
    Wendy B
    Vaccine; 2012 Jul; 30(35):5293-7. PubMed ID: 22575163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.